Skip to main content
. 2019 Nov 5;8(11):1872. doi: 10.3390/jcm8111872

Table 2.

Characteristics of randomised clinical trials on the effect of continuous positive airway pressure on blood pressure levels in patients with sleep apnoea and resistant/refractory hypertension.

Studies Randomisation
(Complete Follow-Up)
Age BMI ESS Anti-HT Drugs SBP/DBP (mmHg)
at Entry
BP Measure AHI, Sleep Study CPAP Use Follow-Up
Lozano et al., 2010 [77] 29 to CPAP
35 to control
59.2 (9.9) 30.8 (5) 6.14 (3.3) 3.48 (0.57) 129.9 (13.7)/76 (10) ABPM 52.3 (21.5)
Full PSG
5.6 (1.52) 3 months
Pedrosa et al., 2013 [83] 19 to CPAP
16 to control
56 (1) 32 (28–39) 10 (1) 4 (4–5) 162 (4)/97 (2) ABPM 29 (24–48)
PSG
6.01 (0.2) 6 months
Martinez-Garcia et al., 2013 [17] 98 to CPAP
96 to control
56 (9.5) 34.1 (5.4) 9.1 (3.7) 3.8 (0.9) 144.2 (12.5)/83 (10.5) ABPM 40.4 (18.9)
RP
5 (1.9) 3 months
De Oliveira et al., 2014 [78] 24 to CPAP
23 to sham
59.4 (7.7) 29.8 (4.4) 10 (6–15) 4 (1) 148 (17)/88 (13) ABPM 20 (18–1)
RP
5.3 (4.1–7.1) Median (IQR) 8 weeks
Muxfeldt et al., 2015 [71] 57 to CPAP
60 to control
60.5 (8.2) 33.4 (5.3) 11 (6) 5 (3–8) 129 (16)/75 812) ABPM 41 (21)
PSG
4.8 (median) 6 months
Navarro et al., 2019 * [80] 23 to CPAP
19 to control
61.1 (8.3) vs. 56.7 (9) 34.9 (5.4) vs. 34.1 (6.8) 9 (4) vs. 8.9 (3.8) 5 (5–6) vs. 5 (5–6) (median, IQR) 154.1 (12.2)/82.9 (14.2)
149(11.5)/84.1 (10.8)
ABPM 42.7 (17.2) vs. 40.4 (20.3)
RP
5.2 (1.5) 3 months

* This study investigate the effect of CPAP on refractory hypertension. Data expressed by mean (standard deviation), unless indicated otherwise. BMI: Body Mass Index; ESS: Epworth Sleepiness Scale; anti-HT: antihypertensive; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; AHI: Apnoea Hypopnoea Index; CPAP: Continuous Positive Airway Pressure; ABPM: 24h-Ambulatory Blood Pressure Monitoring; RP: Respiratory Polygraphy; PSG: Polysomnography; IQR: Interquartile range).